You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(603259.SH):擬首次授予的權益總數調至1844.0177萬股
格隆匯 11-25 18:10

格隆匯11月25日丨藥明康德(603259.SH)公佈,公司於2019年11月25日召開第一屆董事會第三十七次會議,審議通過了《關於調整公司2019年限制性股票與股票期權激勵計劃激勵對象名單和授予數量的議案》,根據公司2019年第一次臨時股東大會、2019年第二次A股類別股東會、2019年第二次H股類別股東會的授權,公司董事會對無錫藥明康德新藥開發股份有限公司2019年限制性股票與股票期權激勵計劃激勵對象名單和授予數量進行調整

此次限制性股票與股票期權激勵計劃授予的激勵對象人數由2534人調整為2467人;此次限制性股票與股票期權激勵計劃擬首次授予的權益總數由1894.9977萬股調整為1844.0177萬股。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account